Skip to main content
ADPT
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
2
Price
$13.53
Mkt Cap
$2.083B
52W Low
$7.16
52W High
$20.76
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, ADPT was trading at $13.53 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $7.16 to $20.76. This filing was assessed with an importance score of 2 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ADPT - Latest Insights

ADPT
Apr 24, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Adaptive Biotechnologies Files Definitive Proxy for Annual Meeting, Details Executive Compensation and Equity Plan Expansion
Sentiment: Neutral
View Wiseek Article
ADPT
Mar 16, 2026, 8:40 PM EDT
Filing Type: 144
Importance Score:
9
Officer Harlan Robins Files Intent to Sell $6.8M in Shares Following Recent Vesting
Sentiment: Negative
View Wiseek Article
ADPT
Mar 16, 2026, 8:33 PM EDT
Filing Type: 144
Importance Score:
8
Adaptive Biotechnologies Officer & Director Files Intent to Sell $6.8M in Stock
Sentiment: Negative
View Wiseek Article
ADPT
Feb 26, 2026, 4:31 PM EST
Filing Type: 10-K
Importance Score:
8
Adaptive Biotechnologies Reports Strong 2025 Financials, Reduced Losses, and Positive Adjusted EBITDA
Sentiment: Positive
View Wiseek Article
ADPT
Feb 05, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Adaptive Biotechnologies Reports Strong Q4 & FY2025 Results, Achieves MRD Profitability, Guides for 2026 Growth
Sentiment: Positive
View Wiseek Article
ADPT
Jan 12, 2026, 8:15 AM EST
Filing Type: 8-K
Importance Score:
8
Adaptive Biotechnologies Reports Strong Preliminary 2025 Results, Projects Profitability by End of 2026
Sentiment: Positive
View Wiseek Article